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ABSTRACT
TREX2 is a 3′-DNA exonuclease specifically expressed in keratinocytes. Here, we 
investigated the relevance and mechanisms of TREX2 in ultraviolet (UV)-induced skin 
carcinogenesis. TREX2 expression was up-regulated by chronic UV exposure whereas 
it was de-regulated or lost in human squamous cell carcinomas (SCCs). Moreover, 
we identified SNPs in the TREX2 gene that were more frequent in patients with head 
and neck SCCs than in healthy individuals. In mice, TREX2 deficiency led to enhanced 
susceptibility to UVB-induced skin carcinogenesis which was preceded by aberrant 
DNA damage removal and degradation as well as reduced inflammation. Specifically, 
TREX2 loss diminished the up-regulation of IL12 and IFNγ, key cytokines related to 
DNA repair and antitumor immunity. In UV-treated keratinocytes, TREX2 promoted 
DNA repair and passage to late apoptotic stages. Notably, TREX2 was recruited to low-
density nuclear chromatin and micronuclei, where it interacted with phosphorylated 
H2AX histone, which is a critical player in both DNA repair and cell death. Altogether, 
our data provide new insights in the molecular mechanisms of TREX2 activity and 
establish cell autonomous and non-cell autonomous functions of TREX2 in the  
UVB-induced skin response.
INTRODUCTION
TREX2 is a non-processive 3′–5′ exonuclease that 
may be involved in genome maintenance by editing 3′-ends 
in multiple pathways, ranging from DNA replication, 
recombination and repair to degradation. The structure, 
biochemical properties, and molecular mechanisms of 
TREX2 in DNA interactions and catalysis in vitro have been 
well characterized [1–3], but less is known about its functions 
and mechanisms in vivo. Although studies in embryonic stem 
cells have shown that Trex2 deletion leads to spontaneous 
chromosomal rearrangements [4] and inactivation of Trex2 
exonuclease leads to double strand breaks (DSBs) [5] Trex2 
knockout mice (Trex2 −/−) do not exhibit a spontaneous 
cancer-prone phenotype or chromosomal instability 
[6], as would be expected if TREX2 had a relevant 
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DNA-editing role. However, a chemically-induced skin 
carcinogenesis protocol revealed impaired keratinocyte 
apoptosis and an increased tumor incidence in the absence 
of TREX2 [6]. Furthermore, TREX2 ectopic co-expression 
with rare-cleaving endonucleases demonstrates that TREX2 
can alter the normal function of end-joining DSB repair 
pathways. TREX2 processing of 3′-ends abrogates precise 
rejoining of endonuclease-induced breaks through the non-
homologous end joining (NHEJ) pathway that determines 
resolution of mutagenic breaks [7–9]. Recent work in a 
heterologous cellular context shows that TREX2 can be a 
component of the error-free post-replication repair (EF-PRR) 
system, which is required to bypass damage that blocks 
replicative DNA polymerases [10]. Thus, upon DNA damage 
TREX2 can potentially participate in multiple pathways 
related to maintenance of genome stability. However, the 
physiological relevance of TREX2 in native cells remains 
elusive.
Unlike the ubiquitous expression of other 3′ 
exonucleases, TREX2 is specifically expressed in 
keratinocytes [6], cells that are naturally exposed 
to exogenous DNA damaging effects, such as UVB 
radiation and environmental chemicals, which are major 
risk factors for the development of cutaneous squamous 
cell carcinomas (cSCCs) and head and neck SCCs 
(HNSCCs), respectively [11, 12]. Keratinocytes display 
several efficient protective mechanisms to counteract 
harmful effects of UVB on DNA, most likely as result of 
evolutionary pressure. In response to UVB, keratinocytes 
undergo either apoptosis or cell cycle arrest depending 
on their intracellular status, the extent and persistence of 
DNA damage, and the balance between survival and death 
signals [13, 14]. In addition, UVB exposure triggers a 
coordinated immune response to maintain skin homeostasis 
[15, 16]. Deregulation of any of these pathways may 
contribute to the onset of UVB-induced skin cancers.
In the present study, we demonstrate a 
multifunctional role for TREX2 in the skin response to 
UVB using Trex2−/− mice and keratinocytes. Upon UVB 
exposure, TREX2 promotes the elimination of DNA 
damage through DNA repair and cell death mechanisms, 
and drives an anti-tumoral immunity, thus suppressing skin 
carcinogenesis. Mechanistically, we provide evidences 
that TREX2 interacts with γH2AX. Furthermore, 
consistent with a role for TREX2 in keratinocyte-derived 
carcinogenesis, sequence polymorphisms in the TREX2 
gene and aberrant TREX2 expression were found in 
human squamous carcinogenesis.
RESULTS
TREX2 is altered in UVB-irradiated skin, actinic 
keratosis lesions and squamous cell carcinomas
We first analyzed whether the UVB radiation targets 
TREX2 expression on mouse skin. Notably, acute UVB 
irradiation transiently down-regulated, while chronic 
exposure highly up-regulated TREX2 expression, as 
clearly showed by immunofluorescence (Fig. 1A) and 
RT-qPCR (Fig. 1B) assays. Immunofluorescence images 
also reveal that TREX2 expression was mainly detected in 
the suprabasal layers of the epidermis, where keratinocytes 
became differentiated as evidenced by keratin 10 (K10) 
expression (Supplemental Fig. 1A). Consistently, in 
primary keratinocyte cultures, strong TREX2 staining 
was associated with the expression of involucrin 
(Supplemental Fig. 1B). Both K10 and involucrin 
expression are induced during keratinocyte differentiation 
[17]. The specificity of TREX2 immunolabeling was 
validated by the absence of staining in the skin and 
keratinocytes from Trex2−/− mice [6] (Supplemental 
Fig. 1A-1B). Therefore, these results demonstrated that 
TREX2 expression in keratinocytes was regulated during 
differentiation and by UVB radiation.The analysis of 
TREX2 by immunofluorescence in human precancerous 
actinic keratosis lesions and keratinocyte-derived tumors, 
including cSCCs (Fig. 1C-1D) and HNSCCs (Table 1), 
revealed a frequent deregulated expression of this 
exonuclease in squamous carcinogenesis. TREX2 staining 
in healthy skin was primarily detected in the granular 
cell layer of the epidermis. Interestingly, in actinic 
keratosis lesions, TREX2 expression increased in upper 
keratinocyte layers and displayed predominantly nuclear 
localization. Furthermore, TREX2 levels and patterns 
of expression in cSCCs varied depending on the degree 
of tumor differentiation and metastasis. Thus, TREX2 
staining exhibited a heterogeneous pattern throughout the 
tumor, but was relatively intense in differentiated areas 
of mainly non-metastatic and well-differentiated tumors. 
In addition, strong TREX2 staining was also detected in 
tumor-associated stroma for a significant subset of non-
metastatic cSCCs. In contrast to this, loss of TREX2 
expression was significantly associated to metastatic 
cSCC, and poorly differentiated tumors. Analogously, 
in HNSCCs, the absence of TREX2 expression was 
significantly associated with nodal metastasis and 
advanced disease stages (Table 1). Curiously, in cSCCs the 
percentage of non-metastasic tumors with loss of TREX2 
expression is lower (17%) than in HNSCC (59%).
We next compared genetic variability of the 
exonuclease TREX2 by sequencing the human TREX2 
gene in tumor and blood samples obtained from HNSCC 
patients and healthy controls. Five rare non-synonymous 
SNPs (L15Q, R132W, R156L, A157T and G161S) and two 
synonymous SNPs were identified in the TREX2 coding 
sequence (Table 2). In addition, one common and nine rare 
SNPs were detected in the non-coding intron sequence 
upstream of the TREX2 coding region. SNPs were present 
in both blood and tumor samples indicating a germline 
origin. These single amino acid variants were expressed 
in homozygosis because the TREX2 gene is located on the 
X chromosome and all coding variants were found in male 
patients. The relatively robust activities of all TREX2 
variants using ss- and dsDNA assays demonstrate that 
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Figure 1: TREX2 expression is up-regulated in chronic UVB-irradiated skin and actinic keratosis lesions, whereas it is 
deregulated or lost in cSCC. A. TREX2 immunostaining and B. mRNA expression in acute and chronic UVB-irradiated mouse skin. 
Graph shows mean and SEM of at least 5 mice. Differences between untreated and UVB-treated skin: unpaired Student’s t test (*P < 0.05; 
***P < 0.001). C. TREX2 expression in healthy human skin, actinic keratosis lesions and cSCCs determined by immunofluorescence. Nuclei 
were counterstained with DRAQ5 or DAPI, as indicated. White dotted lines demarcate the epidermal-dermal border. Original magnification, 
40 × (A) and 20 × (C) D. Evaluation of TREX2 expression in cSCCs for features of metastasis and differentiation. P values of Chi-square 
test are indicated.
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these variants are not complete loss-of-function mutations 
(Fig. 2). Overall, the relatively modest 2-fold differences 
in ssDNA and dsDNA degradation activities detected in the 
R132W, A157T, G161S and L15Q variants seem unlikely 
to affect overall cellular exonuclease activity, in contrast 
to the 6.5-fold lower dsDNA degradation activity detected 
in the R156L variant. However, we cannot rule out a 
greater level of TREX2 exonuclease dysfunction caused 
by these variants within the context of chromatin DNA 
degradation in the cell. Also, functional consequences of 
these genetic variants might be mediated through altered 
in vivo protein-protein or protein-DNA interactions. 
Consistent with this idea the R132, R156, A157, and G161 
residues are positioned on the TREX2 surface ideally 
located to interact with other cellular molecules or with 
DNA [3]. The L15 residue interacts hydrophobically with 
L126 and L127 to appropriately position the alpha helix 
on which the R132 resides. The R156, A157, and G161 
residues are positioned on the same flexible loop between 
helices α6–α7 containing R163, R165, and R167 that 
we previously demonstrated directly contribute to DNA 
binding in the TREX2 enzyme [3]. Thus, the identified 
TREX2 variants are in positions to disrupt interactions by 
multiple mechanisms. Interestingly, when grouping all rare 
TREX2 SNPs, the frequency in affected individuals was 
higher than in controls (Table 2).
TREX2 deficiency enhances susceptibility to 
UVB-induced skin tumorigenesis
To determine the relevance of TREX2 in 
UVB-induced skin carcinogenesis, we compared the 
susceptibility of wt and Trex2−/− mice to the development 
of skin tumors (Fig. 3). The majority of tumors that 
developed in wt and Trex2−/− mice localized to the ear 
(Supplemental Fig. 2A), but one did form on the dorsal 
skin of a Trex2−/− mouse. Trex2−/− mice developed tumors 
earlier, and tumor incidence was significantly greater in 
the Trex2−/− mice relative to their wt counterparts (Fig. 3A; 
P = 0.025, Log-rank Mantel-Cox Test). By the end of 
the experiment, 86% of Trex2−/− mice had developed 
tumors, compared to only 43% of wt mice. The average 
number of tumors per mouse was also significantly 
higher in Trex2−/− mice compared to wt (Fig. 3B), while 
Table 1: Relationship between TREX2 expression and clinicopathological features of HNSCC 
patients 
HNSCC 
Characteristic N
Loss of TREX2 
expression n (%) P
Stromal TREX2 
expression n (%) P
pT classification
T1-T2 41 28 (68) 0.719# 12 (29) 0.251#
T3 47 35 (74) 7 (15)
T4 45 34 (76) 9 (20)
pN classification
N0 44 26 (59) 0.014& 14 (32) 0.042&
N1-3 89 71 (80) 14 (16)
Disease stage
I-II 19 10 (53) 0.048& 8 (42) 0.029&
III-IV 114 87 (76) 20 (18)
Pathological grade
Well-differentiated 38 28 (74) 0.323# 8 (21) 0.207#
Moderately 
Differentiated
59 46 (78) 9 (15)
Poorly 
Differentiated
36 23 (64) 11 (31)
Site
Pharynx 65 51 (78) 0.177& 12 (18) 0.528&
Larynx 68 46 (68) 16 (24)
Number and percentage of tumors showing either a loss of TREX2 expression in the squamous 
epithelia or gain of TREX2 expression in the tumor-associated stroma, with statistical evaluation. 
 #Chi-square and &Fisher’s exact tests.
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no differences were seen in tumor size (Fig. 3C), type of 
tumor and tumor invasiveness (Fig. 3D and Supplemental 
Fig. 2B) between the two genotypes. Therefore, TREX2 
deficiency was associated with increased UVB-induced 
skin tumorigenesis, supporting a tumor suppressor role for 
this exonuclease in the skin upon DNA damage.
TREX2 promotes removal of damaged DNA and 
keratinocyte cell death in UVB-irradiated skin
Because the ability of TREX2 to protect the skin 
against UVB-induced carcinogenesis may reside in both 
acute and chronic responses to UVB radiation, which acts 
as both tumor initiator and promoter [17], we examined 
the effects of TREX2 deficiency on DNA damage 
removal and cell death following both single and repeated 
UVB irradiation. Keratinocyte cell death in UV-irradiated 
skin can take place through diverse cell death modes, 
including apoptosis and necrosis, depending on doses and 
frequency of UV irradiation [18]. Immunofluorescence 
analysis of UVB-induced cyclobutane pyrimidine 
dimers (CPD) lesions (Fig. 4A-4B) indicated that 
DNA damage was significantly higher in 
Trex2−/− epidermis 48 hours after acute (5 kJ/m2), and 
Table 2: Genetic variations and frequencies of the human TREX2 gene in patients with HNSCC 
and in healthy individuals. 
Cases (n = 190) Controls (n = 189)
Position on X 
Chromosome
Accession 
number
Major 
allele
Minor 
allele
Position 
vs first 
ORF 
nucleotide
Amino 
acid
Minor 
allele 
samples 
n
Frequency 
(%)
Minor 
allele 
samples 
n
Frequency 
(%)
152712935 rs34107439 C A (−)2047 3 1.579 2 1.058
152712811 rs35426191 G A (−)1922 1 0.526 0 0.000
152712525 rs371785311 G - (−)1637 5 2.632 0 0.000
152712460 rs3020962 T G (−)1571 53 27.895 54 28.571
152712310 rs191272965 G A (−)1421 1 0.526 0 0.000
152712310 rs191272965 G T (−)1421 1 0.526 1 0.529
152712115 rs568161256 G A (−)1227 1 0.526 0 0.000
152711255 rs533718948 T C (−)367 1 0.526 0 0.000
152711060 rs138397873 T A (−)172 2 1.053 0 0.000
152710970 rs62594087 G A (−)82 1 0.526 2 1.058
152710845 rs201756523 A T (+)44 L15Q 1 0.526 0 0.000
152710495 rs547615095 G A (+)274 R132W 1 0.526 1 0.529
152710422 rs199587066 C A (+)467 R156L 2 1.053 0 0.000
152710420 rs570718370 C T (+)469 A157T 1 0.526 0 0.000
152710408 rs200659060 C T (+)481 G161S 2 1.053 2 1.058
152710373 rs150316545 G A (+)516 L172L 0 0.000 1 0.529
152710236 ss1026802600 A G (+)651 R217R 6 3.158 2 1.058
Number in affected 
individuals (Frequency)
Number in control 
individuals (Frequency)
P value
Nonsynonymous SNPs 7 /190 ( 0.037) 3/ 189 (0.016) 0.337
Minor SNPs 29/190 (0.153) 11/189 (0.058) 0.004
Common SNPs 53/190 (0.279) 54/189 (0.286) 0.910
Minor & Common SNPs 82/190 (0.431) 65/189 (0.344) 0.114
P values from Fisher’s exact test are indicated.
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at 24 and 48 hours after chronic (2 kJ/m2 × 3) UVB 
irradiation. Additionally, immunofluorescence (Fig. 4C) 
and western blot (Fig. 4D-4E) analyses of γH2AX, an 
early chromatin modification at sites of DNA DSBs [19], 
indicated that by 48 hours after acute UVB exposure the 
levels of broken DNA were significantly greater in the 
Trex2−/− epidermis compared to wt. Although no obvious 
differences were observed after chronic UVB exposure, 
low levels of γH2AX-positive cells complicated the 
analysis.
Figure 2: Exonuclease activities of wt and mutant TREX2 variants. A. SDS-PAGE analysis of the purified TREX2 variants. 
The migration positions of the molecular weight (MW) standards are indicated. The size difference observed in the R156L variant is due to 
the plasmid construct used for its cloning and expression, which left six fewer residues at its N-terminus compared to the constructs used 
for the other variants. B. ssDNA exonuclease activities. C. dsDNA exonuclease activities. Exonuclease titration reactions and time course 
reactions are shown. The positions of migration of Form II nicked dsDNA (Nicked dsDNA) and circular ssDNA (ssDNA) are indicated. 
D. Relative ssDNA and dsDNA exonuclease activities.
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Notably, analysis of TUNEL labeling, a marker 
of DNA strand breaks with free 3′-OH ends that are 
generated in late-stage cell death modes, including 
apoptosis and necrosis, and in DNA damaged cells 
[19, 20], showed that DNA degradation and cell death in 
damaged keratinocytes were perturbed in the absence of 
TREX2. TUNEL images illustrated a differential labeling 
pattern in Trex2−/− epidermis compared with that of wt 
after UVB irradiation (Fig. 5A). There was a significantly 
lower number of TUNEL-positive nuclei detected in the 
living layers (stratum basale, spinosum and granulosum) 
of the epidermis of Trex2−/− mice compared with that 
of wt at 24 and 48 hours after acute UVB irradiation 
(Fig. 5A-5B), suggesting that loss of TREX2 prevented 
cell death execution. Conversely, there was a significantly 
higher amount of TUNEL-positive chromatin after acute 
and chronic UVB irradiation in the stratum corneum of 
Trex2−/− mice (Fig. 5A-5C), indicating that in the absence 
of TREX2 fragmented DNA accumulated more in 
cornified, dead keratinocytes. Consistently, high amounts 
of TREX2 were observed in TUNEL-positive suprabasal 
cells from UVB-irradiated wt skin (Supplemental Fig. 3). 
TUNEL labeling was not detectable in non-irradiated skin 
of either wt or Trex2−/− skin (Supplemental Fig. 4). Thus, 
these results indicated that TREX2 exonuclease activity 
contributes to the degradation of DNA in UVB-irradiated 
epidermal keratinocytes whereas it was redundant under 
non-stressed conditions.
The relatively reduced amount of TUNEL, γH2AX 
and CPD positive cells detected after chronic UVB 
exposure would be related to the lower dose used for 
chronic (2 kJ/m2) compared to acute (5 kJ/m2) UVB 
irradiation. Also, chronic UVB irradiation can lead 
to acquisition of resistance to apoptosis (Ouhtit et al, 
2000). Altogether, these results suggested that TREX2 
was involved in the degradation of DNA from dying 
Figure 3: TREX2 deficiency increases susceptibility to UVB-induced skin carcinogenesis. Wt (n = 9) and Trex2−/− (n = 9) 
mice were subjected to the UVB skin carcinogenesis protocol as detailed in Materials and Methods. A. Tumor incidence in Trex2−/− mice 
using Kaplan-Meier survival analysis of tumor-bearing mice. B. Tumor multiplicity in Trex2−/− mice. Average number of tumors per 
mouse. Graphs show mean values and SEM. C. Size distribution and D. histopathological analysis of skin tumors from UVB-treated wt and 
Trex2−/− mice at the end of the experiment. Significant differences between genotypes: (A) Mantel-Cox test (P = 0.025) and (B) Mann-
Whitney test (from left to right #P = 0.0198, #P = 0.0198, and #P = 0.0321).
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keratinocytes upon UVB irradiation, and in the absence 
of TREX2 a fraction of keratinocytes with DNA damage 
failed to undergo cell death.
Loss of TREX2 alters inflammatory and immune 
gene signatures in UVB-irradiated skin
The histopathological analysis of UVB-irradiated 
skin revealed that Trex2−/− mice developed less UVB-
induced skin inflammation than wt (Fig. 6A). In addition, 
the UVB-induced increase in epidermal thickness was 
significantly less pronounced in Trex2−/− than in wt mice 
after chronic UVB exposure (Fig.6B). Specifically, the 
relative amounts of epithelial abscesses and dermal 
inflammatory infiltrates were lower in Trex2−/− skin than in 
wt skin 48 hours after acute UVB irradiation (Fig. 6C). Wt, 
but not Trex2−/− skin, consistently displayed perifollicular 
immune cell infiltration 24 hours after chronic UVB 
exposure. At these stages, immunostaining using 
markers of myeloid cells (CD11b+) and T lymphocytes 
(CD3+) showed that the extent of UVB-induced myeloid 
infiltration, which mostly include neutrophils, natural 
killers and macrophages, was significantly diminished 
in Trex2−/− skin compared to wt, whereas no differences 
were observed in the UVB-induced depletion of 
T cells (Fig. 6D, Supplemental Fig. 5A). Therefore, 
in the absence of TREX2 primary innate immune cell 
response to UVB was compromised. Notably, although 
chronic inflammation is generally associated with tumor 
progression, tumor immunosurveillance is mainly related 
with early activation of innate immunity that further 
modulates the adaptive immune response to eventually 
eliminate transformed cells [18, 21].
Interestingly, the absence of TREX2 impaired 
induction of several key immune genes by UVB 
(Fig. 6E), in agreement with the phenotype displaying 
lower myeloid immune cell infiltration observed in the 
Trex2−/− skin compared to wt. Specifically, the acute 
Figure 4: Loss of TREX2 triggers the highest accumulation of UVB-induced DNA damage in the skin. A. CPD 
immunostaing and B. percentage of CPD-positive epidermal cells and in UVB-irradiated skin from wt and Trex2−/− mice. Significant 
differences between genotypes: Mann-Whitney test (#P < 0.05; ##P < 0.01). C. γH2AX immunostaining, D. western blots analysis of 
γH2AX and H2AX, and E. quantification of blotting bands. Values were normalized to the amount of H2AX and are presented as arbitrary 
units. P value is #P = 0.035 calculated by unpaired Student’s test. Graphs show mean and SEM of at least 4 mice. Nuclei were counterstained 
with DRAQ5. White dotted lines demarcate the epidermal-dermal border. Original magnification, 40x.
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UVB-induced up-regulation of IL6, CAMP and Raet1e 
at 24 and 48 hours, and TNFα and IL12α at 48 hours 
was significantly lower in Trex2−/− skin compared with 
wt. Similarly, 24 hours after chronic UVB irradiation, 
increases in the mRNA of TNFα, IL12α, Raet1e, CAMP, 
IFNγand the IFNγ-dependent genes CXCL10, CCL5 
and iNOS were significantly less in Trex2−/− than in 
wt skin. Consistent with these findings, UVB-induced 
phosphorylation of STAT1 and STAT3, which are 
triggered by IFNγ and IL6 signaling, respectively, was 
reduced in Trex2−/− skin compared to wt (Fig. 6F). No 
significant differences were found in the UVB-induced 
increase in IL1β, IL1α, IL10, TGFβ, IFNκ, and IRF7 
mRNA expression in Trex2−/− skin compared with wt 
Figure 5: TREX2 is involved in DNA processing and facilitates cell death in UVB-irradiated skin. A. TUNEL staining 
in UVB-irradiated skin of wt and Trex2−/− mice. Nuclei were counterstained with DRAQ5. White dotted lines demarcate the epidermal-
dermal border. Inserts are higher magnifications of boxes. Representative images are shown. Original magnification, 63x. B. Quantitative 
analysis of the UVB-induced TUNEL pattern labeling in the epidermal living layers and C. the stratum corneum. TUNEL-positive nuclei 
number and percentage of lineal TUNEL-labeling pattern are relative to epidermis length. Significant differences between genotypes: 
Mann-Whitney test (#P < 0.05; ##P < 0.01). Graphs show mean and SEM of at least 4 mice from each genotype.
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Figure 6: UVB-induced inflammatory response in skin is impaired by the absence of TREX2. A. H&E staining of 
Trex2−/− and wt skins showing UVB-induced abscess formation, inflammatory infiltrate and epidermal hyperplasia. Perifollicular immune 
infiltration (arrows), abscess formation and epidermal hyperplasia are reduced in Trex2−/− skin compared to wt. Original magnification was 
10x. B. Epidermal hyperplasia was evaluated by measuring thickness. C. Abscess number is relative to epidermis length. D. Inflammatory 
infiltrate was evaluated by immunostaining of myeloid cells (CD11b+) and T lymphocytes (CD3+) and represented as the mean number 
of cells counted from at least four images captured at the indicated high-power fields. E. Expression of UVB-induced immune genes, as 
determined by RT-qPCR. Graphs show mean and SEM of at least four mice from each condition and genotype. F. Levels of STAT1 and 
STAT3 tyrosine-phosphorylation in acute and chronic UVB-treated skin of wt and Trex2−/− mice were assessed by western blot. Significant 
differences by Mann-Whitney test between genotypes: #P < 0.05, ## P < 0.01 and compared to non-irradiated samples: *P < 0.05, 
**P < 0.01, ***P < 0.001.
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(Supplemental Fig. 5B). Collectively, these data highlight 
the relevance of TREX2 in promoting UVB-induced skin 
inflammatory and immune responses.
Trex2 deficiency impairs DNA repair and hinders 
cell death in UVB-irradiated keratinocytes
To evaluate the role of TREX2 in the keratinocyte 
response to UVB while excluding crosstalk with other skin 
cells, we analyzed DNA repair, cell cycle progression, 
and apoptosis in UV-treated wt and Trex2−/− keratinocytes. 
Analysis of unscheduled DNA synthesis (UDS) by 
3H-thymidine incorporation, as a measure of global 
genome repair [22], revealed that TREX2 deficiency 
reduced DNA repair synthesis in UVC-treated 
keratinocytes (Fig. 7A). Similarly, UVB (75 J/m2)-
treated wt keratinocytes showed DNA repair (108 + 2, 
9%, n = 3, over non irradiated cells), but it was absent in 
Trex2−/− keratinocytes (99, 9 + 3, 4%, n = 3, over non 
irradiated cells). On the other hand, TREX2 deficiency 
in cultured keratinocytes was significantly associated 
with a slight but consistent decrease in the percentage of 
SubG1 apoptotic cells after UVC and UVB irradiation 
(Fig. 7B). Wt and Trex2−/− keratinocytes displayed similar 
cell cycle progression after exposure to UVC and UVB 
with both inducing G1 phase checkpoint arrest (Fig. 7B). 
Interestingly, FACS analysis showed that TREX2 
deficiency hindered the passage of UVB-irradiated 
keratinocytes to late (Annexin-V and Live_Dead double-
positive) non-reversible apoptotic stages (Fig. 7C-7D). 
Consistently, release of nucleosomes into the cytoplasm, 
a characteristic feature of DNA fragmentation associated 
with cell death by apoptosis, was reduced in UVB-
treated Trex2−/− keratinocytes compared to wt (Fig. 7E). 
No differences in nucleosome release were observed 
between the two genotypes when caspases were inhibited 
by Z-VAD-FMK (Fig. 7E), suggesting that TREX2 acts 
downstream of caspases facilitating DNA degradation in 
UVB-treated keratinocytes.
Indeed, data from survival colony assays indicated 
that Trex2−/− keratinocytes were more resistant to UVB 
than were wt (Fig. 7F). In agreement, stable expression 
of exogenous YFP-TREX2 in HaCaT cells increased the 
susceptibility to UVB radiation when compared to cells 
expressing YFP as a control.
Collectively, these results indicated that TREX2 in a 
cell-autonomous manner played critical roles in promoting 
keratinocyte apoptosis over DNA repair and cell survival 
upon UV irradiation.
TREX2 accumulates in low-density chromatin 
regions and in micronuclei
TREX2 accumulated in skin suprabasal 
keratinocytes and, interestingly, in the vicinity of 
condensed nuclear DNA (Fig. 8A). Also, in primary 
keratinocytes cultures, upon Ca2+ addition (Fig. 8B), which 
triggers keratinocyte differentiation, or UVB irradiation 
(Fig. 8C-8F, 8H-8J), the immunofluorescence labeling 
revealed that multiple, discrete TREX2 foci were present 
in areas of low-density chromatin in nuclei that were 
beginning to condensate chromatin while undergoing cell 
death, which was indicated by TUNEL-positive staining 
(Fig. 8H-8I). In contrast, TREX2 was not detected in 
chromatin bodies of late apoptotic cells (Fig. 8C, 8I), 
suggesting a transient action of TREX2 during apoptosis 
progression. Moreover, an intense nuclear staining pattern 
of TREX2 was observed in detaching involucrin-positive 
keratinocytes committed to cell death via differentiation 
(Fig. 8J, 8K). Interestingly, strong TREX2 labeling was 
observed in micronuclei of either single or multinucleated 
keratinocytes (Fig. 8D, 8E). Notably, the size and density 
of TREX2 foci in micronuclei of binucleated cells after 
treatment with the cytokinesis inhibitor cytochalasin-B 
(Cyt-B) was higher than in the original nuclei (Fig. 8F), 
suggesting that TREX2 was accumulated in chromatin that 
was not incorporated into daughter nuclei during mitosis. 
In fact, TREX2 was also present in mitotic chromatin 
(Fig. 8G). Accordingly, YFP-TREX2 (Fig. 8L-8P), but 
not YFP (Fig. 8Q-8R), ectopically expressed in HaCaT 
cells was abundantly localized in apoptotic, micronuclear 
and mitotic chromatin, relative to nucleosomal 
chromatin. Thus, these data suggest that TREX2 could 
be differentially recruited to distinct chromatin states 
associated to DNA degradation during keratinocyte death 
and differentiation.
TREX2 is recruited to micronuclear damaged 
DNA, interacting with γH2AX
To assess whether TREX2 was distributed at sites 
of damaged DNA, we performed confocal microscopy 
analysis of TREX2 and γH2AX immunostaining. In UVC-
irradiated cells through 5 μm micropore filters, TREX2 
was not recruited to nuclear sites of localized γH2AX 
formation (Fig. 9A-9B), whereas Rad51 accumulated 
at sites of damaged DNA (Supplemental Fig. 6) as 
previously described [23]. We only detected overlap of 
TREX2 with a few nucleosomal γH2AX foci in globally 
UVB-irradiated keratinocytes (Fig. 9C). Interestingly, 
abundant TREX2 co-localization with uniformly 
labeled γH2AX was frequently observed in micronuclei 
(Fig. 9A, 9D). Importantly, γH2AX is required for DNA 
degradation during cell death [24] and homogeneous 
γH2AX labeling affecting all micronuclear chromatin is 
associated with its specific degradation independent of 
nuclear degradation [25]. In this context, UVB radiation 
triggered a significant increase in the frequency of 
micronuclei that were TREX2 positive (Fig. 9G, 9H), 
γH2AX positive (Fig. 9J) and γH2AX-TREX2 double 
positive (Fig. 9I). However, no significant differences 
were observed in the frequency of basal or UVB-induced 
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micronuclei (Fig. 9K-9L) or γH2AX-positive micronuclei 
(Fig. 9J) between wt and Trex2−/− keratinocytes, indicating 
that TREX2 is not involved in micronuclei formation. 
Nevertheless, we cannot exclude that micronuclear DNA 
content differs between the two genotypes. Furthermore, 
substantial co-localization of TREX2 and γH2AX 
occurred in detaching keratinocytes in culture (Fig. 9E) 
and skin suprabasal keratinocytes (Fig. 9F) undergoing 
Figure 7: TREX2 deficiency impairs DNA repair and hinders apoptosis in UV-treated keratinocytes. A. Unscheduled 
DNA synthesis (UDS) in UVC-irradiated wt and Trex2−/− keratinocytes. Data represent percentage of 3H-thymidine incorporation over 
non-irradiated cells. B. Cell cycle progression in wt and Trex2−/− UV-irradiated keratinocytes. Percentages of cells in the SubG1 phase are 
indicated. C. FACS analysis of Annexin-V and LIVE/DEAD® labeled wt and Trex2−/− keratinocytes. D. Percentages of unlabelled (live), 
single-Annexin-V positive (early apoptotic) or double-labeled (late apoptotic) cells are indicated. E. UVB-induced DNA fragmentation in 
wt and Trex2−/− keratinocytes. Where indicated, cells were pre-treated with Z-VAD-FMK for one hour. DNA fragmentation is displayed 
relative to untreated cells. F. Keratinocyte survival in the response to UVB. Clonogenic survival of wt and Trex2−/− keratinocytes and HaCaT 
cells expressing YFP or YFP-TREX2 irradiated with the indicated doses of UVB. Graphs show mean and SEM of at least three independent 
experiments. Images from a representative experiment from three total replicates are shown in B and C. P values between genotypes by 
unpaired Student’s t test: #P < 0.05, ##P < 0.01, unpaired Student’s t-test.
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UVB-induced cell death. Therefore, TREX2 and γH2AX 
co-localization seemed to be associated with DNA 
degradation rather than DNA repair.
Indeed, co-immunoprecipitation assays demonstrated 
that TREX2 interacted with γH2AX in UVB-treated HaCaT 
cells overexpressing YFP-TREX2 protein (Fig. 9M). 
This interaction was independent of its binding to DNA 
since was not abrogated by DNAse treatment of cell 
extracts prior to co-immunoprecipitation assay. In addition, 
γH2AX associates with TREX2, by MBP pull-down assays 
(Fig. 9N). These observations indicate that TREX2 could 
gain access to DNA ends by interacting with γH2AX.
Figure 8: TREX2 accumulates in regions of low-density chromatin and in micronuclei. A. Mouse skin exposed to 
chronic UVB (2 kJ/m2) radiation, B. Ca2+-treated mouse keratinocytes, C-E; H-J. mouse keratinocytes exposed to UVB (150 J/m2) or 
F. to Cytochalasin B (Cyt-B) prior to UVB, and G. non-treated keratinocytes undergoing mitosis or K. differentiation were stained with 
TREX2 and involucrin antibodies and TUNEL, as indicated. L-P. HaCaT cells stably expressing ectopic YFP-TREX2 or Q-R. YFP were 
(L, M and Q) exposed to UVB (150 J/m2), or to (N) Cyt-B prior to UVB or (O, P and R) left untreated. Nuclei were counterstained with 
DRAQ5 or DAPI, as indicated. Representative images were shown. Original magnification was 63x (A-K) and 100x (L-R)
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DISCUSSION
Altogether, our results show that in the skin response 
to UVB radiation, TREX2, an exonuclease specifically 
expressed in keratinocytes, regulates keratinocyte cell 
death and, as a result, skin inflammatory and immune 
responses, that are crucial to counteract carcinogenic 
effects of the UV radiation. In damaged keratinocytes, 
TREX2 intrinsically affects DNA degradation rather 
than DNA repair, prompting cell death execution and 
Figure 9: TREX2 co-localizes and interacts with γH2AX in micronuclei. A. HaCaT cells expressing exogenous YFP-TREX2 
and B. primary keratinocytes UVC-irradiated (100 J/m2) through 5-μm micropore filters, C. keratinocytes globally-irradiated with UVB 
(150 J/m2), D. containing micronuclei or E. detaching, and F. UVB-treated skin samples were stained with γH2AX and TREX2 antibodies, 
as indicated. G. Percentage of TREX2 single-positive micronuclei scored in the absence and H. in the presence of Cyt-B, and I. micronuclei 
double-positive for TREX2 and γH2AX or J. single-positive for γH2AX. K. Micronuclei frequency in untreated or UVB-irradiated 
(150 J/m2) wt and Trex2−/− keratinocytes in the absence or L. presence of Cyt-B. In the presence of Cyt-B, only binucleated cells were 
scored. The data represent the mean and SEM of three independent experiments (G, I, J, K), and the mean of one (H, L) analysis of up to 
1, 000 cells. M. TREX2 interacts with γH2AX as shown by coimmunoprecipitation of γH2AX and YFP-TREX2 after UVB (150 J/m2) 
irradiation of HaCaT cells stably expressing YFP-TREX2 and by N. MBP pull-down assays. Nuclei were counterstained with DRAQ5 
or DAPI, as indicated. Original magnification was 100x (A) and 63x (B-F) P values between untreated and UVB-treated keratinocytes 
calculated by unpaired Student’s t test: *P < 0.05, **P < 0.01.
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subsequently driving a skin immune response associated 
with increased DNA repair and immune surveillance. 
Interestingly, we discovered that TREX2 interacts with 
γH2AX, a critical player in DNA repair that is also 
required for DNA degradation in either apoptosis or 
necrosis cell death modes [24]. A model for the role of 
TREX2 in UV-irradiated skin is depicted in Figure 10.
TREX2 deficiency increases skin carcinogenesis 
induced by chemical [6] or UVB radiation (Fig. 3A). In 
support of a relevant tumor suppressor role for TREX2 
in squamous tumorigenesis, we observed alterations 
in the TREX2 gene and TREX2 expression in human 
SCCs. Similar to NM23-H1, a tumor suppressor that 
also possess 3′-5′ exonuclease activity [26], TREX2 is 
highly expressed in premalignant lesions, but is lost with 
tumor dedifferentiation. Regarding TREX2 gene, our data 
confirms that somatic mutations are not among the diverse 
genetic alterations that accumulate in HNSCC [27], but 
the slightly higher incidence of rare TREX2 variations in 
SCC patients suggests that genetic variability might be 
a predisposing factor for the onset of carcinogenesis. To 
date, only a few rare SNPs in nucleotide excision repair 
(NER) and Fanconi anemia genes have been associated 
with susceptibility to squamous carcinogenesis [28, 29]. 
Interestingly, the TREX2 R156L variant, which results 
in a significant loss of function, presents also a slightly 
higher frequency in sporadic prostate cancers [30]. In 
this context, a germline TREX2 inactivating mutation 
has been reported in one colorectal cancer patient [31]. 
Further evaluation of large cohorts should provide insights 
into a putative association of TREX2 variants with SCC 
susceptibility.
The results showed here support that upon UV 
irradiation, TREX2 facilitates both DNA repair and cell 
death. However, the pro-apoptotic activity of TREX2 
dominates its pro-survival activity, highlighting a critical 
role for TREX2 in DNA damaged-induced cell death. 
Our data indicate that TREX2 does not participate 
Figure 10: A model for the molecular events of TREX2 in UV-irradiated skin. UV irradiation causes DNA damage 
in epidermal keratinocytes. TREX2 contributes to DNA repair which facilitates the survival of cells with limited 
damage. In severely damaged cells, TREX2 is active in DNA degradation during cell death, leading to inflammatory signals that 
subsequently activate innate immune cells. The immune regulatory cytokine response is associated with increased DNA repair capacity 
and immune surveillance of the epidermis. The dual effect of TREX2 is, at least partly, mediated by its interaction with γH2AX, a critical 
player of the DNA damage response that displays a critical role in both DNA repair and cell death execution. Loss of TREX2 function leads 
to increased keratinocyte genomic instability and impaired skin immune surveillance after UV irradiation and ultimately to carcinogenesis.
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to a significant degree in the NER pathway, which is 
responsible for removing primary UV-induced lesions. 
This is consistent with a lack of contribution of 3′-5′ 
exonuclease activity to NER molecular mechanisms 
[32, 33]. On the other hand, ectopic co-expression of 
TREX2 with the i-Sce1 endonuclease has demonstrated 
that degradation of DNA 3′-ends by TREX2 exonuclease 
activity avoids restoration of the i-Sce1 site after end 
joining repair [8]. Indeed, TREX2 can paradoxically 
modify DNA repair via EF-PRR and NHEJ pathways either 
in a positive or negative way [8, 10], and its prevalence 
would most likely be determined by the type of DNA lesion 
and cellular context. For instance, there is a significant 
diversity in the DNA repair and apoptosis responses to 
UV among keratinocytes and fibroblasts [34]. Our data 
clearly indicate that in primary keratinocytes, TREX2 
promotes apoptosis progression to late stages, when the 
death of keratinocytes carrying DNA breaks is ensured. 
Analogously, the nonprocessive 3′-5′ exonuclease TREX1 
has been shown to be involved in DNA degradation from 
the 3′-ends generated by the NM23-H1 endonuclease 
during granzyme A-mediated cell death [35]. Importantly, 
TREX2 interacts with γH2AX, which plays a critical role 
in both DNA repair and DNA degradation [24, 36], in the 
context of the chromatin-degrading state that is present in 
micronuclei and nuclei of keratinocytes undergoing cell 
death via apoptosis, necrosis or differentiation programs 
[13, 25, 37]. It is therefore tempting to speculate that the 
TREX2-γH2AX interaction might be part of the DNA 
degradosome [24], thereby participating directly in DNA 
degradation once 3′-ends are available in cells undergoing 
DNA damage-induced cell death.
UV radiation elicits complex cellular signaling 
and keratinocyte-immune cell crosstalk that leads 
to coordinated immune response to maintain skin 
homeostasis and immune surveillance against cancer 
[15, 16]. Danger signals such as self-DNA from stressed 
and dying keratinocytes trigger the production of type I 
interferons and pro-inflammatory cytokines [38]. 
Unexpectedly, TREX2 deficiency reduces inflammation 
and does not lead to a differential type I interferon response 
signature. This is in spite of the highest accumulation 
of fragmented DNA in corneocytes from Trex2−/− skin. 
Most likely, DNA in the stratum corneum becomes 
inaccessible to skin plasmacytoid dendritic cells, which 
are the major type I IFN producers after sensing DNA 
fragments. In contrast, signals from dying keratinocytes, 
more abundant in wt than Trex2-deficient skin upon UVB 
exposure, can be easily sensed by dendritic and natural 
killer cells, which are responsible for secretion of major 
pro-inflammatory cytokines. Importantly, our findings 
reveal that TREX2 drives an immunoregulatory cytokine 
signature associated with increased DNA repair and anti-
tumorigenic functions. Specifically, loss of TREX2 leads 
to reduced UVB-induction of genes that play a pivotal 
role in skin immune surveillance, such as IL12, IFNγ, 
CXCL10, and Raet1e [39, 40]. In fact, IL12 is required 
for UV-induced DNA damage repair in skin through 
NER [41]. The highest levels of DNA damage in Trex2-
deficient skin after UVB exposure could be attributed to 
the lowest induction of this cytokine. Notably, IL-12 and 
IFNγ are well-known drivers of cytotoxic T cells, which 
inhibit initiation and progression of skin cancer [21]. 
Furthermore, decreased up-regulation of IL6 and TNFα, 
pro-inflammatory cytokines that regulate keratinocyte 
proliferation and cell death [42, 43], correlates with 
the reduced apoptosis, hyperplasia and inflammation 
observed in Trex2-deficient skin following UVB exposure. 
Therefore, TREX2 positively regulates the inflammatory 
response in contrast to the negative role of the closely 
related TREX1 exonuclease [44, 45], supporting the 
specific and non-redundant roles of these exonucleases 
as key regulators of inflammation. TREX1 plays an 
essential role in immune silencing of DNA by degrading 
endogenous cytosolic ssDNA [46], retroelements [47], 
and unmodified DNA [48] during normal homeostasis. 
In addition, unlike TREX2, TREX1 protects against 
cell death following UVC radiation [49]. An intriguing 
question is how TREX2 triggers UVB-induced positive 
inflammatory function. This may be related to its activity 
promoting cell death. Damage-associated molecular 
patterns, including modified nucleic acids, released 
from dead cells [18] elicit activation of innate immune 
receptors leading to a pro-inflammatory response [38]. 
Also, TNFR1-induced keratinocyte apoptosis leads to 
skin inflammation [50, 51]. Furthermore, because short 
DNA fragments induce stronger inflammatory response 
than long fragments do [52], it is tempting to hypothesize 
that TREX2 can contribute to shorter DNA fragments, 
thus favoring DNA sensing rather than immune silencing. 
Further insight into the mechanisms by which TREX2 
regulates skin immunity under stress conditions may have 
major implications in the understanding of inflammatory 
skin diseases. Our findings suggest that TREX2 can be part 
of relevant keratinocyte defense mechanisms against UVB 
and other environmental mutagenic threats or stressors.
MATERIALS AND METHODS
Mice and UVB treatments
The Trex2−/− mouse has been described previously [6]. 
Trex2−/− and wt C57BL/6 mice were housed in a specific-
pathogen-free environment according to the requirements 
of the Ethics Committee on Animal Care of Parc Científic 
of Barcelona. All experiments were conducted under the 
authorization of the Catalan Government (DAAM 7067). 
The UVB light source was from a CL-1000M Midrange 
Ultraviolet Crosslinker (UVP Inc.) that emitted UVB 
light at a wavelength of 302 nm. UVB treatments were 
applied to the ears and back skin, previously shaved with 
electric clippers, of 8 to 10 week-old female mice. For the 
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photocarcinogenesis study, we followed an established 
protocol with minor modifications [53]. Briefly, mice from 
each genotype were irradiated three times per week for 
12 weeks with UVB at a dose of 2 kJ/m2 per exposure, 
followed by the next 12 weeks with 3 kJ/m2 per exposure 
and 5 kJ/m2 per exposure for the final 26 weeks. Mice were 
visually inspected weekly, and tumor numbers and sizes 
were evaluated to calculate tumor incidence (percentage 
of tumor-bearing mice) and tumor multiplicity (average 
number of tumors per mouse). Mice were sacrificed when 
they showed signs of poor health. For the studies on the 
short term effects of UVB, wt and Trex2−/− mice were 
evaluated in two experimental stages: (i) 24 and 48 hours 
following exposure to a single dose of UVB (5 kJ/m2), and 
(ii) 24 and 48 hours after the last exposure to repeated UVB 
exposures (2 kJ/m2) on three non-consecutive days. These 
stages are referred to as acute and chronic UVB exposure, 
respectively. Control mice were shaved but received no 
UVB exposure. These experiments were conducted and 
repeated in 4 to 7 individual animals of each genotype 
per experimental group. Skin samples were collected for 
histological evaluation and RNA and protein analyses.
Human samples
Cutaneous SCC (cSCCs) [54] and HNSCC [55] 
tissue microarrays (TMAs) have been described 
previously. DNA samples from patients diagnosed 
with an HNSCC and those from healthy controls were 
obtained from the Banco Nacional de ADN (University 
of Salamanca, Spain). Approval was obtained by the 
ethics committees from all participating centers and in 
accordance with the guidelines of the Helsinki Declaration.
TREX2 genotyping in HNSCC
DNA extraction from blood and tumor samples with 
quality controls was performed by Banco Nacional de 
ADN following standard procedures. The PCR products 
of the 3265 bp region (X Chromosome: 152710145-
152713410) covering the entire TREX2 coding sequence 
and un-translated regions were directly sequenced. PCR 
reactions were performed using the Expand High Fidelity 
PCR system (Roche) in 50 μl reaction volumes containing 
50 ng genomic DNA and 10 μM primers (sequences are 
available upon request). Purified PCR products (Pure Link 
PCR purification kit, Life Technologies) were sequenced 
on both strands using the BigDye Terminator v3.1 Cycle 
Sequencing Kit and analyzed on an ABI prism 3730 
(Applied Biosystems).
TREX2 variant generation and exonuclease 
activity assays
Human TREX2 variants were generated by site-
directed mutagenesis, cloned into the pLM303x plasmid 
and then purified as described [56]. The R156L variant 
was previously generated in a plasmid construct that 
left six fewer residues at the N-terminus compared to 
the constructs used for the other variants, resulting in 
a lower molecular weight. The ssDNA and dsDNA 
exonuclease activities were assayed as previously 
described [56]. For ssDNA exonuclease activity, 
standard reactions were prepared with a fluorescein-
labeled 30-mer oligonucleotide and dilutions of the 
recombinant TREX2 variants were prepared at 10 times 
their final concentrations. Samples containing the TREX2 
enzymes were added to the reactions to yield the final 
indicated concentrations. The incubations were 30 min 
at 25°C. The reaction products were then subjected to 
electrophoresis on 23% urea-polyacrylamide gels and 
quantified. For dsDNA exonuclease activity, titration 
and time course reactions were prepared with nicked-
dsDNApMYC plasmid. Reactions were performed at the 
designated concentrations for 30 min and the reaction 
products subjected to electrophoresis on agarose gels and 
visualized by ethidium bromide staining. Time course 
reactions were performed with 200 nM of each TREX2 
variant and samples were removed prior to addition of 
the enzyme (0 min) and at the indicated incubation times. 
The reaction products were quenched in 15x SYBR Green 
II, and remaining dsDNA was determined by emission at 
520 nm. The plot of TREX2 activity was generated using 
SigmaPlot 8.02 (SPSS Science, Inc.).
Cell lines and UV treatment, apoptosis, cell cycle 
and survival assays
Primary keratinocytes were prepared from newborn 
mouse skin and cultured in CNT-02 medium (CELLnTEC) 
for up to seven days, as previously described [6]. 
Immortalized HaCaT keratinocyte cells stably expressing 
exogenous YFP (HaCaT_YFP) or YFP fused to mouse 
TREX2 (HaCaT_YFP-TREX2) and grown in DMEM 
supplemented with 10% FBS, were selected with G418 
(100 μg/mL; Sigma) and sorted by flow cytometry (MoFlo 
Astrios, Beckman Coulter).
Cells were exposed to UV irradiation after removal 
of the medium using UVB (UVP Inc.) or UVC (Sankyo 
Denki) lamps at a distance of 50 cm, followed by the 
addition of fresh medium. A radiometer with UVX-25 
and UVX-31 sensors was used (UVP Inc.) to monitor UV 
dose. Wt and Trex2−/− keratinocytes were either untreated 
or irradiated with UVB or UVC at the indicated doses. To 
measure UDS (Lehmann & Stevens, 1980), keratinocytes 
were cultured in CNT-02 medium without growth factor 
supplements and with 20 mM hydroxyurea for 3 hours 
to inhibit semi-conservative DNA replication. The cells 
were then UV-irradiated and incubated for an additional 
3 hours in the same fresh media containing 20 μCi/ml 
3H-thymidine. Incorporation of 3H-thymidine into acid-
insoluble materials was measured by liquid scintillation 
counting.
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UV-induced cell death was assessed 18 hours 
post-irradiation and evaluated to detect DNA fragments 
released into the cytoplasm using the Cell Death Detection 
ELISAPLUS kit (Roche) according to the manufacturer’s 
protocol. Progression of apoptosis was determined 
with the Annexin V-FITC Apoptosis Detection kit 
(eBioscience) and the LIVE_DEAD-Far Red reagent (Life 
Technologies). Cells were stained prior harvesting to avoid 
keratinocyte membrane damage by trypsin. The stained 
cells were analyzed by flow cytometry (FACSCanto II, 
Becton Dickinson). Annexin-positive cells corresponded 
to early apoptotic cells while Annexin-positive plus strong 
positive-LIVE_DEAD-Far Red cells corresponded to late 
apoptotic cells.
To determine the effects of UVB radiation on 
cell survival, clonogenic assays were performed. Cells 
(2, 5# × # 105 primary keratinocytes or 10, 000 HaCaT_
YFP and HaCaT_YFPTREX2) were seeded on 6-well 
plates in duplicate, and treated with the indicated doses. 
Ten days after treatment, the colonies were stained with 
methylene blue following standard procedures, scored and 
used to calculate the surviving fraction of cells in each 
condition.
Cell cycle was assessed 18 hours post-irradiation. 
Fixed cells were stained with propidium iodide (Sigma) 
following a standard procedure and analyzed by flow 
cytometry (FACSCanto II, Becton Dickinson). For cell 
cycle progression analysis, debris and residuals of necrotic 
cells were gated off during the analysis of data, as they 
have minimal DNA fluorescence and reduced diameter 
compared to apoptotic cells [57].
Micronuclei were evaluated in the presence and 
absence of Cytochalasin B (Cyt-B, 0.5 μg/mL, Sigma) to 
block cytokinesis. In this assay, only binucleated dividing 
cells were taking into account for micronuclei scoring [58].
For keratinocyte immunofluorescence assays, cells 
grown on collagen-coated glass coverslips were left 
untreated, globally irradiated or irradiated through a filter 
with 5 μm pores.
Histological and immunofluorescence analyses
Skin and tumor samples from mice were fixed with 
4% paraformaldehyde in PBS, embedded in paraffin and 
then cut in 5 μm sections. Sections were stained with 
hematoxylin and eosin (H&E) for histopathological 
evaluation. Tumors were grouped as papillomas and non-
invasive SCC, invasive SCC, and sarcomatoid tumors.
Epidermal thickness in H&E stained sections was 
measured as the distance, in the interfollicular epidermis, 
between the top of the basement membrane and the 
bottom of the stratum corneum at 4 points of 2 randomly 
selected 20x fields from each animal using the Image 
J software (NIH).
For skin immunostaining analyses, indirect 
immunofluorescence and immunohistochemistry standard 
procedures were used. Skin sections were deparaffinized 
and rehydrated, and antigen retrieval was performed in 
citrate buffer (pH 6.0) for CPD staining or Tris-EDTA buffer 
(pH 9.0) for TREX2, involucrin, K10, CD3, CD11b and 
γH2AX staining. The following primary antibodies were 
used: affinity-purified rabbit anti-mouse TREX2 (1/50; in 
house [6]), mouse anti-K10 (1/200; ab9026, Abcam), mouse 
anti-involucrin (1/200; I9018; Sigma) rabbit anti-CD3 
(1/200; ab5690, Abcam), rabbit anti-CD11b (1/200; ab75476, 
Abcam);) mouse anti-CPD (1/500; COSMO BIO CO), and 
mouse anti-γH2AX (Ser139) (1/500; Upstate) antibodies. 
For immunofluorescence, goat anti-mouse IgG coupled to 
Alexa Fluor 488 and goat anti-rabbit IgG coupled to Alexa 
Fluor 555 (1/500; Life Technologies) were used as secondary 
antibodies. Image J software (NIH) was used to quantify the 
percentage of positive-labeled cells in at least four fields 
selected randomly from each section in a blinded manner.
Similarly, TMAs of cSCC were processed with Tris-
EDTA buffer (pH 9.0) for indirect immunofluorescent 
detection of TREX2 and involucrin by rabbit anti-human 
TREX2 (1/100; in house) and mouse anti-involucrin 
(1/200; Sigma) antibodies. 3-μm sections of HNSCC 
TMAs were deparaffinized and treated using the Envision 
Flex Target Retrieval solution low pH. Incubation 
with rabbit anti-human TREX2 (1/100; in house) 
antibody was done on an automatic staining workstation 
(DakoAutostainer Plus) using the DakoEnVision Flex + 
Visualization System. Samples were counterstained 
with hematoxylin. For analysis of TREX2 expression 
in SCCs, immunostaining was independently evaluated 
by two observers in a blinded manner, and data were 
dichotomized as negative-weak expression (score 0) 
versus moderate-strong expression (score 1) either in the 
tumor epithelia or the stroma.
For keratinocyte staining, cells were fixed with 4% 
paraformaldehyde in PBS and permeabilized with 0.1% 
Triton X-100 in PBS. The samples were then blocked and 
incubated with affinity purified rabbit anti-mouse TREX2 
and anti-Rad51 (1/100; Santa Cruz Biotechnologies), 
and mouse anti-γH2AX, anti-involucrin, and anti-CPD 
antibodies as described above. For anti-CPD labeling, after 
permeabilization, cells were treated with 2 M HCL for 
30 min to denature DNA. Goat anti-mouse IgG coupled 
to Alexa Fluor 488 and goat anti-rabbit IgG coupled to 
Alexa Fluor 555 (1/500; Life Technologies) were used as 
secondary antibodies.
Cell and tissue TUNEL-labeling using the In Situ 
Cell Death Detection Kit Fluorescein (Roche) was 
performed prior to antibody incubation and following 
the manufacturer instructions. TUNEL and epidermis 
length were quantified along at least 1 cm section using 
Metamorph software (Molecular Devices, Sunnyvale) in a 
blinded manner and the average of the images calculated.
Nuclei and micronuclei were counterstained with 
DRAQ5 (Biostatus Limited) or DAPI (Sigma). Slices 
were mounted in ProLong Gold Anti-Fade reagent 
(Life Technologies).
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Microscopic imaging
Confocal images were obtained using a Leica 
TCS-SL filter-free spectral confocal laser scanning 
microscope (Leica Microsystems, Germany). 
Conventional images were captured with a Nikon Eclipse 
E-800 fluorescence microscope.
Quantitative RT-PCR analysis
Total RNA isolated from pulverized skin (NucleoSpin 
RNA extraction kit, Macherey-Nagel) was used for cDNA 
synthesis (GeneAmp RNA PCR kit, Applied Biosystems). 
Quantitative PCR amplification reactions were performed 
in the 7500 Fast Real-Time PCR System (Applied 
Biosystems). TaqMan assays (Applied Biosystems) were 
used to quantify the mRNA expression of mouse TREX2 
(Mm04210320_m1), TNFα(Mm00443258_m1), IL6 
(Mm00446190_m1), IL1β (Mm00434228_m1), IL1α 
(Mm00439620_m1), IL10 (Mm00439616_m1), IFNγ 
(Mm00801778_m1), CXCL10 (Mm00445235_m1), 
CCL5 (Mm01302427_m1), TGFβ (Mm00441724_m1), 
Mx1 (Mm00487796_m1), Camp (Mm00438285_m1), 
IFNβ (Mm00439552_s1), IFNα (Mm03030145_gH) 
and SDHA (Mm01352366_m1). The following primers 
were used to quantify mRNA expression: mouse L12α 
(Forward (F), 5′GTACCAGACAGAGTTCCAGG; 
Reverse (R), 5′CGCAGAGTCTCGCCATTATG), 
IFNκ (F, 5′CTGACAGTCTACCTGGAGTTG; R, 
5′GTTCTTGCTTGAAGGTGGGTG), iNOS (F, 
5′CTCGGAGGTTCACCTCACTG; 
R, 5′GTGCTGCAGACACCATGGTG), IRF7 (F, 
5′GAGCAAGACCGTGTTTACG; 
R, 5′CATGATGGTCACATCCAGG), and Raet1e 
(F, 5′AGCAGTGACCAAGCGCCATC; R, 
5′CCTTGATGGTCAAGTTGCAC). Samples prepared 
without reverse transcription enzyme served as negative 
control templates. Values were normalized to SDHA 
expression because of its suitability as a reference gene in 
UVB-irradiated keratinocytes [59] and data were expressed 
as arbitrary units.
Protein extracts, co-immunoprecipitation,  
pull-down and western blotting analyses
Whole cell and skin extracts for western blotting 
were obtained in ice-cold lysis buffer containing 1% 
Nonidet P-40, 1% deoxycholate, 0.1% SDS, 50 mmol/L 
HEPES pH 7.5, and 150 mmol/L NaCl, together with 
protease and phosphatase inhibitors (10 μg/ml aprotinin, 
10 μg/ml leupeptin, 86 μg/ml iodoacetamide, and 1 mM 
PMSF, 1 mM Na3VO4) as described [6]. Histones 
were acid extracted with 0.2 M HCL. Cell extracts for 
co-immunoprecipitation and pull-down assays were 
obtained in ice-cold lysis buffer containing 1% NP-40, 
10% glycerol, 50 mmol/L HEPES pH 7.5, 150 mmol/L 
NaCl, and the previously mentioned inhibitors. 
Immunoprecipitated complexes were washed four times 
with buffer containing 20 mmol/L HEPES pH 7.5, 0.1% 
Nonidet P-40, 10% glycerol, and 150 mmol/L NaCl. 
Samples were boiled in Laemmli buffer and separated by 
SDS-PAGE. Western blotting was performed as previously 
described (Parra et al, 2009). Primary antibodies used 
throughout this study include, rabbit anti-mouseTREX2 
(1/1000; in house [6]), anti-phospho-STAT1 (Tyr701), 
anti-phospho-STAT3 (Tyr705) (1/1000; Cell Signaling), 
and anti-H2AX (1/1000; Abcam), and mouse anti-γH2AX 
(Ser139), anti-βactin (1/10000; Sigma), and anti-GFP 
(1/2000; Roche). Horseradish peroxidase-conjugated 
goat anti-rabbit or goat anti-mouse antibodies (1/10000; 
BioRad) were used as secondary antibodies. Detection 
was performed with enhanced chemiluminescence (ECL, 
Biological Industries). For co-immunoprecipitation, 1 mg 
of protein extracts from untreated and UVB-irradiated 
HACAT_YFP and HACAT_YFP-TREX2 cells were 
incubated with anti-GFP magnetic beads (MBL). For 
pull-down assays, 2 mg of protein extracts from untreated 
and UVB-irradiated keratinocytes were incubated with 
MBP or MBP-TREX2 fusion proteins bound to amylose 
magnetic beads (New England Biolabs).
Statistical analyses
Statistical analyses were conducted using GraphPad 
Prism 5 SoftwareTM. The Mann-Whitney test was used for 
analysis of tumor multiplicity at single time points and 
for comparisons between mouse genotypes or treatment 
conditions. Tumor incidence was analyzed using the Log-
rank (Mantel-Cox). The unpaired Student’s t test was 
applied for analysis of keratinocyte data. Associations 
between TREX2 expression and categorical variables of 
SCCs were analyzed using the χ2 and Fisher’s exact tests, 
as appropriate. P values of ≤ 0.05 were considered to be 
statistically significant.
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